These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 33969)
21. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia. Sovner R; Dimascio A Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992 [No Abstract] [Full Text] [Related]
22. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB; Caligiuri MP J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552 [TBL] [Abstract][Full Text] [Related]
23. A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients. Chouinard G; Annable L; Kropsky M J Clin Pharmacol; 1978; 18(2-3):148-54. PubMed ID: 24061 [TBL] [Abstract][Full Text] [Related]
25. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations. Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051 [TBL] [Abstract][Full Text] [Related]
26. HLA antigens in drug-induced parkinsonism. Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491 [TBL] [Abstract][Full Text] [Related]
27. Drug-induced parkinsonism: relationship to age at onset of schizophrenia. Sandyk R; Kay SR Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777 [TBL] [Abstract][Full Text] [Related]
28. An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia. Hanin B; Lerner Y; Srour N Convuls Ther; 1995 Dec; 11(4):271-4. PubMed ID: 8919580 [TBL] [Abstract][Full Text] [Related]
29. Movement disorders in patients with coexistent neuroleptic-induced tremor and tardive dyskinesia: EMG and pharmacological study. Rondot P; Bathien N Adv Neurol; 1987; 45():361-6. PubMed ID: 2881446 [No Abstract] [Full Text] [Related]
30. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures. Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737 [TBL] [Abstract][Full Text] [Related]
31. Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Gelenberg AJ; Doller JC; Schooler NR; Mieske M; Severe J; Mandel MR Am J Psychiatry; 1979 Feb; 136(2):217-9. PubMed ID: 367182 [No Abstract] [Full Text] [Related]
32. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Cortese L; Caligiuri MP; Williams R; Schieldrop P; Manchanda R; Malla A; Harricharan R J Clin Psychopharmacol; 2008 Feb; 28(1):69-73. PubMed ID: 18204344 [TBL] [Abstract][Full Text] [Related]
33. A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. Mindham RH; Lamb P; Bradley R Br J Psychiatry; 1977 Jun; 130():581-5. PubMed ID: 326325 [TBL] [Abstract][Full Text] [Related]
34. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism. Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599 [No Abstract] [Full Text] [Related]